» Articles » PMID: 16232226

P-selectin Glycoprotein Ligand-1 (PSGL-1) is Up-regulated on Leucocytes from Patients with Chronic Obstructive Pulmonary Disease

Overview
Date 2005 Oct 20
PMID 16232226
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic obstructive pulmonary disease (COPD) is characterized by a dysregulated recruitment of circulating leucocytes into the lung which is associated with the onset and progress of the disease. P-selectin glycoprotein ligand-1 (PSGL-1) is expressed on leucocytes and plays an essential role in primary leucocyte-endothelial cell adhesive contacts. The present study investigated if PSGL-1 is up-regulated on leucocytes of COPD patients. Peripheral blood samples were collected from COPD patients as well as controls (smoking, nonsmoking volunteers) and subjected to analysis of PSGL-1 expression on leucocytes, i.e. neutrophils, eosinophils, monocytes and lymphocytes by flow cytometry. No significant difference was observed between healthy nonsmoking and healthy smoking control subjects. In contrast, PSGL-1 expression was found to be significantly increased on the surface of all four leucocyte populations in COPD patients compared to both control groups. The finding that PSGL-1 surface expression is up-regulated on leucocytes of COPD patients as compared to leucocytes of controls suggests PSGL-1 as a potential target for anti-inflammatory treatment.

Citing Articles

P-selectin glycoprotein ligand-1 and cardiovascular diseases: from a general perspective to an HIV infection context.

Zaongo S, Song Y, Chen Y Front Cardiovasc Med. 2025; 12:1521158.

PMID: 40041169 PMC: 11876174. DOI: 10.3389/fcvm.2025.1521158.


PSGL-1 excludes HIV Env from virion surface through spatial hindrance involving structural folding of the decameric repeats (DR).

Tiwari S, Delfing B, Han Y, Lockhart C, Haikerwal A, Waheed A bioRxiv. 2025; .

PMID: 39763838 PMC: 11703279. DOI: 10.1101/2024.12.28.630612.


Integrative Cross-Talk in Asthma: Unraveling the Complex Interactions Between Eosinophils, Immune, and Structural Cells in the Airway Microenvironment.

Januskevicius A, Vasyle E, Rimkunas A, Malakauskas K Diagnostics (Basel). 2024; 14(21).

PMID: 39518415 PMC: 11545034. DOI: 10.3390/diagnostics14212448.


PSGL-1, a Strategic Biomarker for Pathological Conditions in HIV Infection: A Hypothesis Review.

Zaongo S, Chen Y Viruses. 2023; 15(11).

PMID: 38005875 PMC: 10674231. DOI: 10.3390/v15112197.


Defining the versican interactome in lung health and disease.

Tang F, Brune J, Chang M, Reeves S, Altemeier W, Frevert C Am J Physiol Cell Physiol. 2022; 323(2):C249-C276.

PMID: 35649251 PMC: 9291419. DOI: 10.1152/ajpcell.00162.2022.


References
1.
Keatings V, Collins P, Scott D, Barnes P . Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med. 1996; 153(2):530-4. DOI: 10.1164/ajrccm.153.2.8564092. View

2.
Romano S, Slee D . Targeting selectins for the treatment of respiratory diseases. Curr Opin Investig Drugs. 2002; 2(7):907-13. View

3.
Rodgers S, Camphausen R, Hammer D . Tyrosine sulfation enhances but is not required for PSGL-1 rolling adhesion on P-selectin. Biophys J. 2001; 81(4):2001-9. PMC: 1301674. DOI: 10.1016/S0006-3495(01)75850-X. View

4.
Curtis J, Sonstein J, Craig R, Todt J, Knibbs R, Polak T . Subset-specific reductions in lung lymphocyte accumulation following intratracheal antigen challenge in endothelial selectin-deficient mice. J Immunol. 2002; 169(5):2570-9. PMC: 4371789. DOI: 10.4049/jimmunol.169.5.2570. View

5.
Ley K . The role of selectins in inflammation and disease. Trends Mol Med. 2003; 9(6):263-8. DOI: 10.1016/s1471-4914(03)00071-6. View